SOUTHPOINT CAPITAL ADVISORS LP sold 6.1% of their position (246.02K shares) of FENNEC PHARMACEUTICALS INC. on the open market
Open‑market sale worth $2.04M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 11/17/2025ACC: 0001012975-25-000793
10% Owner
Since May 2020
-246.02K
Net shares
Net seller
$2.04M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
246.02K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−160.10K
Price / share
$8.00
Trade value
$1.28M
% of position
4.0%
11/14/2025
4.01M→3.85M
Common Stock
Indirect
Shares
−85.92K
Price / share
$8.79
Trade value
$755.19K
% of position
2.2%
11/17/2025
3.85M→3.76M
Total
Net shares
−246.02K
Net value
-$2.04M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/14/2025 | S · Sale | −160.10K | $8.00 | $1.28M | 4.0% | 4.01M | 3.85M |
| Common Stock Indirect | 11/17/2025 | S · Sale | −85.92K | $8.79 | $755.19K | 2.2% | 3.85M | 3.76M |
| Total | −246.02K | -$2.04M | ||||||
Derivative Transactions0
No derivative transactions reported